Discover opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
This contract includes 1 purchase order from Sep 29, 2023 to Sep 29, 2023
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| Office of Acquisition Managementt Policy | PPD Development, L.P. | Sep 29, 2023 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES PRECLINICAL, REGULATORY, AND MANUFACTURING DEVELOPMENT ACTIVITIES.
Effective Date
Mar 18, 2022
Expires
Effective: Mar 18, 2022
THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES PRECLINICAL, REGULATORY, AND MANUFACTURING DEVELOPMENT ACTIVITIES.
ActiveTHIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF A SECOND-GENERATION, MULTI-ANALYTE MOLECULAR SARS-COV-2 AND INFLUENZA A/B TEST THAT HAS A REDUCED TIME TO RESULT AND INCREASED SENSITIVITY THAT CAN BE USED AT HOME OR A POC SETTING
Effective Date
Jan 24, 2022
Expires
Effective: Jan 24, 2022
THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF A SECOND-GENERATION, MULTI-ANALYTE MOLECULAR SARS-COV-2 AND INFLUENZA A/B TEST THAT HAS A REDUCED TIME TO RESULT AND INCREASED SENSITIVITY THAT CAN BE USED AT HOME OR A POC SETTING
ActiveRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Effective Date
Jan 18, 2019
Expires
Effective: Jan 18, 2019
Expires:
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
ActiveADVANCE THE DEVELOPMENT OF PAAG17G (DRUG PRODUCT: MIIST305), A ONCE DAILY, ORALLY ADMINISTERED, GUT-RESTRICTED DRUG, TO REDUCE MORTALITY AND MORBIDITY ARISING FROM ACUTE EXPOSURE TO IONIZING RADIATION, SPECIFICALLY GASTROINTESTINAL (GI) INJURY (GI-AR
Effective Date
Sep 30, 2024
Expires
Effective: Sep 30, 2024
ADVANCE THE DEVELOPMENT OF PAAG17G (DRUG PRODUCT: MIIST305), A ONCE DAILY, ORALLY ADMINISTERED, GUT-RESTRICTED DRUG, TO REDUCE MORTALITY AND MORBIDITY ARISING FROM ACUTE EXPOSURE TO IONIZING RADIATION, SPECIFICALLY GASTROINTESTINAL (GI) INJURY (GI-AR
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis